Variants Of Concern (vocs) - Vaccines

Relevant Publications

SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.

Issue Release: 2024

UnCoVar: a reproducible and scalable workflow for transparent and robust virus variant calling and lineage assignment using SARS-CoV-2 as an example.

Issue Release: 2024

Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment.

Issue Release: 2024

Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants.

Issue Release: 2024

Single Ferritin Nanocages Expressing SARS-CoV-2 Spike Variants to Receptor and Antibodies.

Issue Release: 2024

Wide Real-Life Data Support Reduced Sensitivity of Antigen Tests for Omicron SARS-CoV-2 Infections.

Issue Release: 2024

Sequencing analysis of SARS-CoV-2 cases in Slovenian long-term care facilities to support outbreak control.

Issue Release: 2024

Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies.

Issue Release: 2024

Bispecific antibodies with broad neutralization potency against SARS-CoV-2 variants of concern.

Issue Release: 2024

Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain.

Issue Release: 2024

Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.

Issue Release: 2024

Rapid Emergence and Evolution of SARS-CoV-2 Variants in Advanced HIV Infection.

Issue Release: 2024

Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection.

Issue Release: 2024

Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2.

Issue Release: 2024

Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens.

Issue Release: 2024

Preclinical Development of a Novel Epitope-based DNA Vaccine Candidate against SARS-CoV-2 and Evaluation of Immunogenicity in BALB/c Mice.

Issue Release: 2024

Age-Related Differences in Neutralizing Antibody Responses against SARS-CoV-2 Delta and Omicron Variants in 151 SARS-CoV-2-Naïve Metropolitan Residents Boosted with BNT162b2.

Issue Release: 2024

Case fatality rates of COVID-19 during epidemic periods of variants of concern: a meta-analysis by continents.

Issue Release: 2024

AlphaFold2 Reveals Structural Patterns of Seasonal Haplotype Diversification in SARS-CoV-2 Spike Protein Variants.

Issue Release: 2024

Genomic Surveillance of SARS-CoV-2: Data Analysis and Assessment of Tunisian Strategy from January 2021 to February 2022.

Issue Release: 2024

What Are the Advantages and Disadvantages of These Vaccines?

What measures are taken to control VDPVs?

Are There Any Risks Associated with Vaccines for People with Heart Disease?

Why is Assessing Vaccine Efficacy Important?

What Factors Contribute to Vaccine Hesitancy?

What Should You Know Before Getting Vaccinated?

What Impact Has UNICEF Had on Global Vaccination?

How to Identify Misinformation?

What are the Limitations of Inactivated Vaccines?

Why is the Immunization Schedule Important?

Partnered Content Networks

Relevant Topics